Zacks: Brokerages Anticipate Anthem, Inc. (NYSE:ANTM) Will Post Earnings of $7.80 Per Share

Wall Street analysts expect Anthem, Inc. (NYSE:ANTMGet Rating) to post earnings of $7.80 per share for the current fiscal quarter, Zacks reports. Seventeen analysts have provided estimates for Anthem’s earnings. The highest EPS estimate is $8.00 and the lowest is $7.70. Anthem posted earnings per share of $7.03 in the same quarter last year, which would indicate a positive year-over-year growth rate of 11%. The company is scheduled to announce its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Anthem will report full year earnings of $28.52 per share for the current year, with EPS estimates ranging from $28.25 to $29.05. For the next fiscal year, analysts anticipate that the business will report earnings of $32.38 per share, with EPS estimates ranging from $31.50 to $32.96. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that cover Anthem.

Anthem (NYSE:ANTMGet Rating) last posted its quarterly earnings data on Wednesday, April 20th. The company reported $8.25 earnings per share for the quarter, beating analysts’ consensus estimates of $7.81 by $0.44. Anthem had a net margin of 4.33% and a return on equity of 18.71%. The firm had revenue of $38.10 billion for the quarter, compared to analyst estimates of $37.28 billion. During the same period last year, the firm posted $7.01 EPS. Anthem’s quarterly revenue was up 17.6% on a year-over-year basis.

Several research firms have issued reports on ANTM. Morgan Stanley boosted their target price on Anthem from $518.00 to $607.00 and gave the stock an “overweight” rating in a research report on Thursday, April 21st. Cowen upped their target price on shares of Anthem from $472.00 to $642.00 in a research report on Thursday, April 21st. SVB Leerink raised their price target on Anthem from $483.00 to $555.00 and gave the company a “market perform” rating in a research report on Thursday, April 21st. Argus lifted their price objective on Anthem from $475.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, February 7th. Finally, BMO Capital Markets increased their price objective on Anthem from $540.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, April 25th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Anthem has an average rating of “Buy” and an average price target of $543.64.

NYSE ANTM opened at $501.93 on Monday. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $121.01 billion, a P/E ratio of 19.76, a P/E/G ratio of 1.41 and a beta of 1.05. Anthem has a 52-week low of $355.43 and a 52-week high of $533.68. The firm has a 50-day moving average price of $485.74 and a 200 day moving average price of $453.90.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 24th. Stockholders of record on Friday, June 10th will be issued a dividend of $1.28 per share. The ex-dividend date is Thursday, June 9th. This represents a $5.12 dividend on an annualized basis and a dividend yield of 1.02%. This is a boost from Anthem’s previous quarterly dividend of $1.13. Anthem’s payout ratio is presently 20.16%.

In other news, EVP Peter D. Haytaian sold 17,703 shares of the stock in a transaction dated Thursday, March 10th. The stock was sold at an average price of $460.71, for a total value of $8,155,949.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ronald W. Penczek sold 2,423 shares of the business’s stock in a transaction that occurred on Thursday, March 3rd. The stock was sold at an average price of $463.68, for a total value of $1,123,496.64. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,889 shares of company stock valued at $10,532,411. Corporate insiders own 0.27% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Great Diamond Partners LLC boosted its stake in shares of Anthem by 15.0% during the 4th quarter. Great Diamond Partners LLC now owns 904 shares of the company’s stock valued at $419,000 after buying an additional 118 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its holdings in Anthem by 28.1% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 65,647 shares of the company’s stock valued at $30,430,000 after acquiring an additional 14,406 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in Anthem by 7.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 27,774 shares of the company’s stock valued at $12,874,000 after acquiring an additional 1,814 shares during the last quarter. Sanders Capital LLC grew its holdings in Anthem by 9.1% during the 3rd quarter. Sanders Capital LLC now owns 3,977,162 shares of the company’s stock worth $1,640,909,000 after acquiring an additional 330,942 shares in the last quarter. Finally, Cozad Asset Management Inc. increased its position in shares of Anthem by 27.3% in the 4th quarter. Cozad Asset Management Inc. now owns 2,724 shares of the company’s stock worth $1,263,000 after purchasing an additional 585 shares during the last quarter. Hedge funds and other institutional investors own 84.28% of the company’s stock.

Anthem Company Profile (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Featured Articles

Get a free copy of the Zacks research report on Anthem (ANTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.